Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The interface between pharmacoepidemiology and pharmacogenetics.

Maitland-van der Zee AH1, de Boer A, H G Leufkens

  • 1Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, P.O. Box 80082, 3508 TB, Utrecht, Netherlands

European Journal of Pharmacology
|January 3, 2001
PubMed
Summary

Genetic pharmacoepidemiology investigates how genetic variations influence drug responses in diverse populations. This field is crucial for understanding individual differences in drug efficacy and side effects, paving the way for personalized medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of infections in patients with gout: a population-based cohort study.

Scientific reports·2017
Same author

Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers' views.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Concomitant drug use among patients on cardiac glycosides.

The International journal of risk & safety in medicine·2013
Same author

Fracture rate in patients with myasthenia gravis: the general practice research database.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Drug regulatory systems must foster innovation.

Science (New York, N.Y.)·2011

Area of Science:

  • Pharmacoepidemiology
  • Pharmacogenetics
  • Genetics

Background:

  • Individual responses to drug therapy vary significantly, impacting both beneficial effects and adverse events.
  • Pharmacogenetics aims to quantify the role of genetic makeup in observed drug response variability.
  • Real-world patient populations offer valuable insights into genetic influences on drug response.

Purpose of the Study:

  • To explore the contribution of genetic variations to differential drug responses in pharmacoepidemiologic research.
  • To investigate the distribution of genetic polymorphisms and their correlation with drug response rates in the general population.
  • To identify novel genetic factors associated with variability in drug response.

Main Methods:

  • Utilizing pharmacoepidemiologic research methods to analyze drug response in patient populations with known genetic profiles.

Related Experiment Videos

  • Examining the prevalence of genetic polymorphisms within general populations.
  • Correlating genetic data with observed patient outcomes (responders vs. non-responders).

    • Main Results:

    • Genetic variations significantly contribute to differences in how individuals respond to medications.
    • Understanding genetic polymorphisms is key to explaining real-world drug response variability.
    • Research is identifying specific genetic links to variable drug efficacy and toxicity.

    Conclusions:

    • Genetic pharmacoepidemiology is essential for understanding personalized drug responses.
    • Future pharmacotherapy will likely move towards 'tailor-made' treatments based on genetic profiles.
    • This field plays a pivotal role in the development and evaluation of personalized medicine strategies.